Antitumor agent-28

Modify Date: 2025-08-27 17:16:51

Antitumor agent-28 Structure
Antitumor agent-28 structure
Common Name Antitumor agent-28
CAS Number 2097499-67-5 Molecular Weight 512.62
Density N/A Boiling Point N/A
Molecular Formula C25H32N6O4S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Antitumor agent-28


Antitumor agent-28 selectively inhibits ataxia telangiectasia mutated (ATM) kinase. Antitumor agent-28 prevents ATM mediated disease and has potent anti-cancer activity[1].

 Names

Name Antitumor agent-28

 Antitumor agent-28 Biological Activity

Description Antitumor agent-28 selectively inhibits ataxia telangiectasia mutated (ATM) kinase. Antitumor agent-28 prevents ATM mediated disease and has potent anti-cancer activity[1].
Related Catalog
Target

ATM

ATR

In Vitro Antitumor agent-28 inhibits ataxia telangiectasia mutated (ATM; IC50=7.6 nM; HT29 cells), ataxia telangiectasia and Rad3-related protein (ATR; IC50=18 μM; HT29 cells), PI3Ka (IC50=0.24 μM; BT474 cells). Antitumor agent-28 does not inhibit mTOR in MDA-MB-468 cells[1].
References

[1]. Kurt Gordon Pike, et al. Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer. WO2017076898A1.

 Chemical & Physical Properties

Molecular Formula C25H32N6O4S
Molecular Weight 512.62
InChIKey CVJOKGCVOABDEN-UHFFFAOYSA-N
SMILES CC(C)n1c(=O)n(C)c2cnc3ccc(-c4ccc(N5CC(N(C)C)C5)nc4)cc3c21.CS(=O)(=O)O
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.